J Pharm Biomed Anal. 2025 Aug 18. pii: S0731-7085(25)00466-2. [Epub ahead of print]266 117125
The most bioactive form of dihydroxylated vitamin D (VD) is 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3), which is implicated in various physiological processes and disease development. Therefore, accurate quantification of 1α,25(OH)2D3 is essential for clinical diagnosis, VD-related disease management, and infection control. However, 1α,25(OH)2D3 quantification in biological samples is challenging because of its low concentration and interference from other dihydroxylated VD metabolites. In this study, we developed a novel assay for 1α,25(OH)2D3 quantification, based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) in combination with protein precipitation, solid-phase extraction (SPE), and derivatization of VD metabolites with 14-(4-dimethylaminophenyl)-9-phenyl-9,10-dihydro-9,10-[1,2]epitriazoloanthracene-13,15-dione (DAP-PA). In the derivatization process, the 6 R and 6S isomers of 1α,25(OH)2D3 obtained in a 1:1 ratio were quantitatively separated and detected using a pentafluorophenyl-octadecylsilyl mix mode column. This approach enabled the complete separation of 1α,25(OH)2D3 from other dihydroxylated VD3s, including 1β,25-dihydroxyvitamin D3 (1β,25(OH)2D3), 3-epi-1α,25-dihydroxyvitamin D3 (3-epi-1α,25(OH)2D3), 2α,25-dihydroxyvitamin D3 (2α,25(OH)2D3), 2β,25-dihydroxyvitamin D3 (2β,25(OH)2D3), 4α,25-dihydroxyvitamin D3 (4α,25(OH)2D3), and 4β,25-dihydroxyvitamin D3 (4β,25(OH)2D3). To demonstrate the applicability of this optimized method, we analyzed human serum and compared the results with a widely used immunoaffinity extraction-based LC-MS/MS assay for 1α,25(OH)2D3, showing equivalent quantitative values. The optimized LC-MS/MS method achieved a run time of 7.7 min, with a lower limit of quantification of 2.5 pg/mL using a sample serum volume of 100 µL. This method is highly sensitive, precise, and capable of high-throughput analysis, providing a robust approach for accurate quantification of 1α,25(OH)2D3 while effectively separating interfering dihydroxylated VD3 isomers.
Keywords: 14-(4-dimethylaminophenyl)-9-phenyl-9,10-dihydro-9,10-[1,2]epitriazoloanthracene-13,15-dione (DAP-PA); 1α,25(OH)(2)D(3); 1β,25(OH)(2)D(3); 4β,25(OH)(2)D(3); Pentafluorophenyl-octadecylsilyl (PFP-C18); Vitamin D